Back
Guangzhou Baiyunshan Pharmaceutical Holdings 10K Form
Sell
15
GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings
Last Price:
2.88
Seasonality Move:
16.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GZPHF News And Ratings
See the #1 stock for the next 7 days that we like better than GZPHF
GZPHF Financial Statistics
Sales & Book Value
| Annual Sales: | $10.68B |
|---|---|
| Cash Flow: | $248.27M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.18 |
| Price / Book: | 0.91 |
Profitability
| EPS (TTM): | 0.29390 |
|---|---|
| Net Income (TTM): | $477.74M |
| Gross Margin: | $2.01B |
| Return on Equity: | 9.09% |
| Return on Assets: | 4.39% |
Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Forecast
Key Guangzhou Baiyunshan Pharmaceutical Holdings Financial Ratios
- The Gross Profit Margin over the past 27 years for GZPHF is 18.79%.
- The Selling, General & Administrative Expenses for GZPHF have been equal to 4.46% of Gross Profit Margin.
- The Research & Development expenses have been 1.04% of Revenue.
- The Interest Expense is 11.00% of Operating Income.
- The Net Earning history of GZPHF is 5.37% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 16 years.
Guangzhou Baiyunshan Pharmaceutical Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | GZPHF |
| Website: | gybys.com.cn |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 1.46 |
| Quick Ratio: | 1.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.17 |
|---|---|
| Forward P/E Ratio: | 0 |
GZPHF Technical Analysis vs Fundamental Analysis
Sell
15
Guangzhou Baiyunshan Pharmaceutical Holdings (GZPHF)
is a Sell
Is Guangzhou Baiyunshan Pharmaceutical Holdings a Buy or a Sell?
-
Guangzhou Baiyunshan Pharmaceutical Holdings stock is rated a Sell
The current Guangzhou Baiyunshan Pharmaceutical Holdings [GZPHF] share price is $2.88. The Score for GZPHF is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.